https://www.selleckchem.com/pr....oducts/l-arginine-l-
The ex vivo biodistribution studies demonstrated that the tumor/liver ratio were 1.80 ± 0.65 and 2.09 ± 0.68 in implanted HepG2 and BEL7402 tumors respectively. Negative control and blocking experiments revealed that the radioactivity uptake in the HCC tumor was LAPTM4B protein-specific. [ F]FP-LAP2H appears to be a potential PET tracer for imaging LAPTM4B-positive HCC tumor. Further endeavors need to do to improve tumor/liver ratio. [18F]FP-LAP2H appears to be a potential PET tracer for imaging LAPTM4B-positive HCC tumor
Like
Comment
Share
